A microbiota-modulated checkpoint directs immunosuppressive intestinal T cells into cancers
Open accessThe DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
Abstract
Antibiotics (ABX) compromise the efficacy of programmed cell death protein 1 (PD-1) blockade in cancer patients, but the mechanisms underlying their immunosuppressive effects remain unknown. By inducing the down-regulation of mucosal addressin cell adhesion molecule 1 (MAdCAM-1) in the ileum, post-ABX gut recolonization by Enterocloster species drove the emigration of enterotropic α4β7 + CD4 + regulatory T 17 cells into the tumor. These deleterious ABX effects were mimicked by oral gavage of Enterocloster species, by genetic deficiency, or by antibody-mediated neutralization of MAdCAM-1 and its receptor, α4β7 integrin. By contrast, fecal microbiota transplantation or interleukin-17A neutralization prevented ABX-induced immunosuppression. In independent lung, kidney, and bladder cancer patient cohorts, low serum levels of soluble MAdCAM-1 had a negative prognostic impact. Thus, the MAdCAM-1–α4β7 axis constitutes an actionable gut immune checkpoint in cancer immunosurveillance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Intestinal dysbiosis, broadly defined as an imbalance in the composition or function of the gut microbiota, is a significant contributor to resistance against immune checkpoint inhibitor (ICI) therapies.1–16,”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“Antibiotics predictably inflict the most acute damage, reducing diversity, depleting beneficial commensals, and permitting blooms of pathobionts like Enterocloster and Streptococcus.4,27,98”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“For instance, our lab has shown that antibiotic-induced dysbiosis spurs the downregulation of mucosal vascular addressin cell adhesion molecule 1 (MAdCAM-1; discussed below) via altered BA metabolism (Fig. 3h).4”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“Our lab recently reported that low baseline sMAdCAM-1 levels are strongly associated with gut dysbiosis in cancer patients.4,24”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
In the citing paper
“This, in turn, allows immunosuppressive gut-resident α4β7+FoxP3+ regulatory Th17 (Tr17) cells to exit the gut and migrate to peripheral tumors, where they can blunt local antitumor immunity.4”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [4]
26 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
limma powers differential expression analyses for RNA-sequencing and microarray studies
Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., & Smyth, G. K. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv007 · Cited by 40,458
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Self-citationQuPath: Open source software for digital pathology image analysis
Bankhead, P., Loughrey, M. B., Fernández, J. A., Dombrowski, Y., McArt, D. G., Dunne, P. D., McQuaid, S., Gray, R. T., Murray, L. J., Coleman, H. G., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17204-5 · Cited by 8,908
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447 · cited 1×
“I mmune checkpoint inhibitors (ICIs) targeting the immunosuppressive interaction between programmed cell death protein 1 (PD-1) and programmed death-ligand 1 (PD-L1) are used in the clinical management of many cancer types (1, 2).”
MethodGut microbiome influences efficacy of PD-1-based immunotherapy against epithelial tumors
Routy, B., Le Chatelier, E., Derosa, L., Duong, C. P. M., Alou, M. T., Daillère, R., Fluckiger, A., Messaoudene, M., Rauber, C., Roberti, M. P., et al. (2018) · Science · doi:10.1126/science.aan3706 · Cited by 5,671 · cited 3×
“Moreover, FMT from some human donors fails to improve ICI responses (7, 35).”
BackgroundMethodSelf-citationIpilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
Robert, C., Thomas, L., Bondarenko, I., O'Day, S., Weber, J., Garbe, C., Lebbe, C., Baurain, J.-F., Testori, A., Grob, J.-J., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1104621 · Cited by 4,496
Vedolizumab as Induction and Maintenance Therapy for Ulcerative Colitis
Feagan, B. G., Rutgeerts, P., Sands, B. E., Hanauer, S., Colombel, J.-F., Sandborn, W. J., Van Assche, G., Axler, J., Kim, H.-J., Danese, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1215734 · Cited by 2,888
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
Spranger, S., Bao, R., & Gajewski, T. F. (2015) · Nature · doi:10.1038/nature14404 · Cited by 2,830 · cited 1×
“, A novel endothelial L-selectin ligand activity in lymph node medulla that is regulated by alpha(1,3)fucosyltransferase-IV.”
BackgroundMultivariable association discovery in population-scale meta-omics studies
Mallick, H., Rahnavard, A., McIver, L. J., Ma, S., Zhang, Y., Nguyen, L. H., Tickle, T. L., Weingart, G., Ren, B., Schwager, E. H., et al. (2021) · PLOS Computational Biology · doi:10.1371/journal.pcbi.1009442 · Cited by 2,596
Analysis of compositions of microbiomes with bias correction
Lin, H., & Peddada, S. D. (2020) · Nature Communications · doi:10.1038/s41467-020-17041-7 · Cited by 2,104
Molecular Signature of CD8+ T Cell Exhaustion during Chronic Viral Infection
Wherry, E. J., Ha, S.-J., Kaech, S. M., Haining, W. N., Sarkar, S., Kalia, V., Subramaniam, S., Blattman, J. N., Barber, D. L., & Ahmed, R. (2007) · Immunity · doi:10.1016/j.immuni.2007.09.006 · Cited by 2,103
Fecal microbiota transplant overcomes resistance to anti–PD-1 therapy in melanoma patients
Davar, D., Dzutsev, A. K., McCulloch, J. A., Rodrigues, R. R., Chauvin, J.-M., Morrison, R. M., Deblasio, R. N., Menna, C., Ding, Q., Pagliano, O., et al. (2021) · Science · doi:10.1126/science.abf3363 · Cited by 1,781 · cited 1×
“In clinical trials, fecal microbial transfer (FMT) frommelanoma patients who benefited from PD-1 blockade circumvents primary resistance to ICIs in one-third ofmetastaticmelanoma recipients (33, 34).”
BackgroundFecal microbiota transplant promotes response in immunotherapy-refractory melanoma patients
Baruch, E. N., Youngster, I., Ben-Betzalel, G., Ortenberg, R., Lahat, A., Katz, L., Adler, K., Dick-Necula, D., Raskin, S., Bloch, N., et al. (2021) · Science · doi:10.1126/science.abb5920 · Cited by 1,757
Gut-Residing Segmented Filamentous Bacteria Drive Autoimmune Arthritis via T Helper 17 Cells
Wu, H.-J., Ivanov, I. I., Darce, J., Hattori, K., Shima, T., Umesaki, Y., Littman, D. R., Benoist, C., & Mathis, D. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.001 · Cited by 1,577
Proinflammatory T-cell responses to gut microbiota promote experimental autoimmune encephalomyelitis
Lee, Y. K., Menezes, J. S., Umesaki, Y., & Mazmanian, S. K. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1000082107 · Cited by 1,323
Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy
Gao, J., Shi, L. Z., Zhao, H., Chen, J., Xiong, L., He, Q., Chen, T., Roszik, J., Bernatchez, C., Woodman, S. E., et al. (2016) · Cell · doi:10.1016/j.cell.2016.08.069 · Cited by 1,300
Self-citationRegulatory T cells are key cerebroprotective immunomodulators in acute experimental stroke
Liesz, A., Suri-Payer, E., Veltkamp, C., Doerr, H., Sommer, C., Rivest, S., Giese, T., & Veltkamp, R. (2009) · Nature Medicine · doi:10.1038/nm.1927 · Cited by 1,115
Commensal microbiota affects ischemic stroke outcome by regulating intestinal γδ T cells
Benakis, C., Brea, D., Caballero, S., Faraco, G., Moore, J., Murphy, M., Sita, G., Racchumi, G., Ling, L., Pamer, E. G., et al. (2016) · Nature Medicine · doi:10.1038/nm.4068 · Cited by 1,114
Th17 and regulatory T cells in mediating and restraining inflammation
Littman, D. R., & Rudensky, A. Y. (2010) · Cell · doi:10.1016/j.cell.2010.02.021 · Cited by 1,039
Individual intestinal symbionts induce a distinct population of RORγ + regulatory T cells
Sefik, E., Geva-Zatorsky, N., Oh, S., Konnikova, L., Zemmour, D., McGuire, A. M., Burzyn, D., Ortiz-Lopez, A., Lobera, M., Yang, J., et al. (2015) · Science · doi:10.1126/science.aaa9420 · Cited by 879
Dangaj, D., Bruand, M., Grimm, A. J., Ronet, C., Barras, D., Duttagupta, P. A., Lanitis, E., Duraiswamy, J., Tanyi, J. L., Benencia, F., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.05.004 · Cited by 875 · cited 1×
“Blockade of the MAdCAM-1–a4b7 axis during PD-1–targeted immunotherapy impaired the infiltration of tumors by effector CCR5 CD8 T cells (59, 60) (Fig.”
BackgroundMicrobiota Dysbiosis Controls the Neuroinflammatory Response after Stroke
Singh, V., Roth, S., Llovera, G., Sadler, R., Garzetti, D., Stecher, B., Dichgans, M., & Liesz, A. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.1114-16.2016 · Cited by 794
Review: microbial transformations of human bile acids
Guzior, D. V., & Quinn, R. A. (2021) · Microbiome · doi:10.1186/s40168-021-01101-1 · Cited by 748
Environmental factors shaping the gut microbiome in a Dutch population
Gacesa, R., Kurilshikov, A., Vich Vila, A., Sinha, T., Klaassen, M. A. Y., Bolte, L. A., Andreu-Sánchez, S., Chen, L., Collij, V., Hu, S., et al. (2022) · Nature · doi:10.1038/s41586-022-04567-7 · Cited by 735 · cited 2×
“were previously identified in the stools of cancer patients resistant to PD-1 blockade (10, 11), as well as in chronic inflammatory disorders (30), and mediate resistance to cancer immunotherapy with PD-1 blockade in mice (31).”
BackgroundDerosa, L., Routy, B., Thomas, A. M., Iebba, V., Zalcman, G., Friard, S., Mazieres, J., Audigier-Valette, C., Moro-Sibilot, D., Goldwasser, F., et al. (2022) · Nature Medicine · doi:10.1038/s41591-021-01655-5 · Cited by 685 · cited 6×
“clinically relevant (10) [(D), middle panel], and volcano plot contrasting significantly different stool taxa of FMT-recipient mice, as assessed using 16S rRNA-seq, selecting bacteria of high prevalence and, according to ileal expression levels of”
InfluentialSelf-citationDynamic regulatory network controlling TH17 cell differentiation
Yosef, N., Shalek, A. K., Gaublomme, J. T., Jin, H., Lee, Y., Awasthi, A., Wu, C., Karwacz, K., Xiao, S., Jorgolli, M., et al. (2013) · Nature · doi:10.1038/nature11981 · Cited by 682 · cited 1×
“Recent intestinal Treg17 emigrants found in tdLNs exhibit gutspecific Treg cell features (69, 70), TH17 cell– related gene expression patterns (71), as well as immunosuppressive traits such as Dusp2/ PCA1 (47) and Pik3ip1 (72).”
Novel bile acid biosynthetic pathways are enriched in the microbiome of centenarians
Sato, Y., Atarashi, K., Plichta, D. R., Arai, Y., Sasajima, S., Kearney, S. M., Suda, W., Takeshita, K., Sasaki, T., Okamoto, S., et al. (2021) · Nature · doi:10.1038/s41586-021-03832-5 · Cited by 632 · cited 1×
“We screened the effects of various biliary acid (37, 38) and bacteria on Madcam1 expression in vitro using twomurine endothelial cell lines, transformed endothelial sinusoidal cells (TSECs) and brain endothelial cells (bEnd.”
MethodThe TCF1-Bcl6 axis counteracts type I interferon to repress exhaustion and maintain T cell stemness
Wu, T., Ji, Y., Moseman, E. A., Xu, H. C., Manglani, M., Kirby, M., Anderson, S. M., Handon, R., Kenyon, E., Elkahloun, A., et al. (2016) · Science Immunology · doi:10.1126/sciimmunol.aai8593 · Cited by 627
The gut microbiota influences anticancer immunosurveillance and general health
Routy, B., Gopalakrishnan, V., Daillère, R., Zitvogel, L., Wargo, J. A., & Kroemer, G. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-018-0006-2 · Cited by 523
Self-citationBriskin, M., Winsor-Hines, D., Shyjan, A. M., Cochran, N. A., Bloom, S. L., Wilson, J., McEvoy, L. M., Butcher, E. C., Kassam, N., Mackay, C. R., et al. (1997) · Europe PMC (PubMed Central) · Cited by 500
Single-Cell Transcriptomics of Regulatory T Cells Reveals Trajectories of Tissue Adaptation
Miragaia, R. J., Gomes, T., Chomka, A., Jardine, L., Riedel, A., Hegazy, A. N., Whibley, N., Tucci, A., Chen, X., Lindeman, I., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.01.001 · Cited by 499 · cited 1×
“Recent intestinal Treg17 emigrants found in tdLNs exhibit gutspecific Treg cell features (69, 70), TH17 cell– related gene expression patterns (71), as well as immunosuppressive traits such as Dusp2/ PCA1 (47) and Pik3ip1 (72).”
BackgroundTomura, M., Yoshida, N., Tanaka, J., Karasawa, S., Miwa, Y., Miyawaki, A., & Kanagawa, O. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802278105 · Cited by 413
Derosa, L., Routy, B., Fidelle, M., Iebba, V., Alla, L., Pasolli, E., Segata, N., Desnoyer, A., Pietrantonio, F., Ferrere, G., et al. (2020) · European Urology · doi:10.1016/j.eururo.2020.04.044 · Cited by 398
Self-citationT cell–induced CSF1 promotes melanoma resistance to PD1 blockade
Neubert, N. J., Schmittnaegel, M., Bordry, N., Nassiri, S., Wald, N., Martignier, C., Tillé, L., Homicsko, K., Damsky, W., Maby-El Hajjami, H., et al. (2018) · Science Translational Medicine · doi:10.1126/scitranslmed.aan3311 · Cited by 308
Role of β7 Integrins in Intestinal Lymphocyte Homing and Retention
Gorfu, G., Rivera-Nieves, J., & Ley, K. (2009) · Current Molecular Medicine · doi:10.2174/156652409789105525 · Cited by 292
Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon
Ward, J. B. J., Lajczak, N. K., Kelly, O. B., O’Dwyer, A. M., Giddam, A. K., Ní Gabhann, J., Franco, P., Tambuwala, M. M., Jefferies, C. A., Keely, S., et al. (2017) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00256.2016 · Cited by 286
Tissue regulatory T cells: regulatory chameleons
Muñoz-Rojas, A. R., & Mathis, D. (2021) · Nature Reviews Immunology · doi:10.1038/s41577-021-00519-w · Cited by 281
Cano-Gamez, K., Soskic, B., Roumeliotis, T. I., So, E., Smyth, D. J., Baldrighi, M., Willé, D., Nakic, N., Esparza-Gordillo, J., Larminie, C. G. C., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-15543-y · Cited by 274
Wirth, T. C., Xue, H.-H., Rai, D., Sabel, J. T., Bair, T., Harty, J. T., & Badovinac, V. P. (2010) · Immunity · doi:10.1016/j.immuni.2010.06.014 · Cited by 261
Elkrief, A., Derosa, L., Kroemer, G., Zitvogel, L., & Routy, B. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz206 · Cited by 246
Self-citationMicrobiome Dependent Regulation of Tregs and Th17 Cells in Mucosa
Pandiyan, P., Bhaskaran, N., Zou, M., Schneider, E., Jayaraman, S., & Huehn, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00426 · Cited by 236
Expression of RORγt Marks a Pathogenic Regulatory T Cell Subset in Human Colon Cancer
Blatner, N. R., Mulcahy, M. F., Dennis, K. L., Scholtens, D., Bentrem, D. J., Phillips, J. D., Ham, S., Sandall, B. P., Khan, M. W., Mahvi, D. M., et al. (2012) · Science Translational Medicine · doi:10.1126/scitranslmed.3004566 · Cited by 211
Krebs, C. F., Paust, H.-J., Krohn, S., Koyro, T., Brix, S. R., Riedel, J.-H., Bartsch, P., Wiech, T., Meyer-Schwesinger, C., Huang, J., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.10.020 · Cited by 207
Endoscopic photoconversion reveals unexpectedly broad leukocyte trafficking to and from the gut
Morton, A. M., Sefik, E., Upadhyay, R., Weissleder, R., Benoist, C., & Mathis, D. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1405634111 · Cited by 199
Critical functions of N-glycans in L-selectin-mediated lymphocyte homing and recruitment
Mitoma, J., Bao, X., Petryanik, B., Schaerli, P., Gauguet, J.-M., Yu, S.-Y., Kawashima, H., Saito, H., Ohtsubo, K., Marth, J. D., et al. (2007) · Nature Immunology · doi:10.1038/ni1442 · Cited by 180
Translation is actively regulated during the differentiation of CD8+ effector T cells
Araki, K., Morita, M., Bederman, A. G., Konieczny, B. T., Kissick, H. T., Sonenberg, N., & Ahmed, R. (2017) · Nature Immunology · doi:10.1038/ni.3795 · Cited by 175
Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0236 · Cited by 170
Self-citationFischer, A., Zundler, S., Atreya, R., Rath, T., Voskens, C., Hirschmann, S., López-Posadas, R., Watson, A., Becker, C., Schuler, G., et al. (2016) · Gut · doi:10.1136/gutjnl-2015-310022 · Cited by 169
Grajeda-Iglesias, C., Durand, S., Daillère, R., Iribarren, K., Lemaitre, F., Derosa, L., Aprahamian, F., Bossut, N., Nirmalathasan, N., Madeo, F., et al. (2021) · Aging · doi:10.18632/aging.202739 · Cited by 161
Self-citationMaximal T Cell–Mediated Antitumor Responses Rely upon CCR5 Expression in Both CD4+ and CD8+ T Cells
González-Martín, A., Gómez, L., Lustgarten, J., Mira, E., & Mañes, S. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1687 · Cited by 151
Voigt, C., May, P., Gottschlich, A., Markota, A., Wenk, D., Gerlach, I., Voigt, S., Stathopoulos, G. T., Arendt, K. A. M., Heise, C., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1705165114 · Cited by 141
Self-citationIL-7 receptor influences anti-TNF responsiveness and T cell gut homing in inflammatory bowel disease
Belarif, L., Danger, R., Kermarrec, L., Nerrière-Daguin, V., Pengam, S., Durand, T., Mary, C., Kerdreux, E., Gauttier, V., Kucik, A., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci121668 · Cited by 138
Mohiuddin, J. J., Chu, B., Facciabene, A., Poirier, K., Wang, X., Doucette, A., Zheng, C., Xu, W., Anstadt, E. J., Amaravadi, R. K., et al. (2021) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djaa057 · Cited by 137
Cutting Edge: CD4+CD25+ Regulatory T Cells Impaired for Intestinal Homing Can Prevent Colitis
Denning, T. L., Kim, G., & Kronenberg, M. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.12.7487 · Cited by 125
A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target
Freeman, Z. T., Nirschl, T. R., Hovelson, D. H., Johnston, R. J., Engelhardt, J. J., Selby, M. J., Kochel, C. M., Lan, R. Y., Zhai, J., Ghasemzadeh, A., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci128672 · Cited by 124
Haas, K. N., & Blanchard, J. L. (2019) · INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY · doi:10.1099/ijsem.0.003698 · Cited by 123
The phosphatase PAC1 acts as a T cell suppressor and attenuates host antitumor immunity
Lü, D., Liu, L., Sun, Y., Song, J., Yin, Q., Zhang, G., Fang, Q., Hu, Z., Yang, Z., Zhou, Z. C., et al. (2020) · Nature Immunology · doi:10.1038/s41590-019-0577-9 · Cited by 122
Yonekura, S., Terrisse, S., Alves Costa Silva, C., Lafarge, A., Iebba, V., Ferrere, G., Goubet, A.-G., Fahrner, J.-E., Lahmar, I., Ueda, K., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0999 · Cited by 112
Self-citationPopulation dynamics of islet-infiltrating cells in autoimmune diabetes
Magnuson, A. M., Thurber, G. M., Köhler, R. H., Weissleder, R., Mathis, D. J., & Benoist, C. O. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423769112 · Cited by 110
Kim, J., Hwang, J., Jung, J. H., Lee, H., Lee, D., & Kim, S. (2019) · Molecular Cancer · doi:10.1186/s12943-019-1110-3 · Cited by 110
Mechanisms of MAdCAM-1 gene expression in human intestinal microvascular endothelial cells
Ogawa, H., Binion, D. G., Heidemann, J., Theriot, M., Fisher, P. J., Johnson, N. A., Otterson, M. F., & Rafiee, P. (2005) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00406.2003 · Cited by 68
M’Rini, C., Cheng, G., Schweitzer, C., Cavanagh, L. L., Palframan, R. T., Mempel, T. R., Warnock, R. A., Lowe, J. B., Quackenbush, E. J., & von Andrian, U. H. (2003) · The Journal of Experimental Medicine · doi:10.1084/jem.20030182 · Cited by 59
Li, L., Patsoukis, N., Petkova, V., & Boussiotis, V. A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045115 · Cited by 56
Multifaceted modes of action of the anticancer probiotic Enterococcus hirae
Goubet, A.-G., Wheeler, R., Fluckiger, A., Qu, B., Lemaître, F., Iribarren, K., Mondragón, L., Tidjani Alou, M., Pizzato, E., Durand, S., et al. (2021) · Cell Death & Differentiation · doi:10.1038/s41418-021-00753-8 · Cited by 54
Self-citationPIK3IP1/TrIP restricts activation of T cells through inhibition of PI3K/Akt
Uche, U. N., Piccirillo, A., Kataoka, S., Grebinoski, S., D’Cruz, L. M., & Kane, L. (2018) · The Journal of Experimental Medicine · doi:10.1084/jem.20172018 · Cited by 53
Rizzo, A., Giovangiulio, M. D., Stolfi, C., Franzè, E., Fehling, H.-J., Carsetti, R., Giorda, E., Colantoni, A., Ortenzi, A., Rugge, M., et al. (2018) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-17-0698 · Cited by 52
Pik3ip1 Is a Negative Immune Regulator that Inhibits Antitumor T-Cell Immunity
Chen, Y., Wang, J., Wang, X., Li, X., Song, J., Fang, J., Liu, X., Liu, T., Wang, D., Li, Q., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4134 · Cited by 48
IL‐17 and anti‐bacterial immunity: Protection versus tissue damage
Cooper, A. M. (2009) · European Journal of Immunology · doi:10.1002/eji.200839090 · Cited by 45
Liver-targeted hydrodynamic gene therapy: Recent advances in the technique
Yokoo, T., Kamimura, K., Abé, H., Kobayashi, Y., Kanefuji, T., Ogawa, K., Goto, R., Oda, M., Suda, T., & Terai, S. (2016) · World Journal of Gastroenterology · doi:10.3748/wjg.v22.i40.8862 · Cited by 43
Gao, R. Y., Shearn, C. T., Orlicky, D. J., Battista, K. D., Alexeev, E. E., Cartwright, I. M., Lanis, J. M., Kostelecky, R. E., Ju, C., Colgan, S. P., et al. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-00347-6 · Cited by 43
Reinisch, W., Sandborn, W. J., Danese, S., Hébuterne, X., Kłopocka, M., Tarabar, D. K., Vaňásek, T., Greguš, M., Hellstern, P. A., Kim, J. S., et al. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab023 · Cited by 42
Th17 Cells in Protection from Tumor or Promotion of Tumor Progression
Young, M. R. (2016) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000431 · Cited by 37
Albiges, L. K., Négrier, S., Dalban, C., Chevreau, C., Gravis, G., Oudard, S. M., Laguerre, B., Barthélémy, P., Borchiellini, D., Gross‐Goupil, M., et al. (2019) · Journal of Clinical Oncology · doi:10.1200/jco.2019.37.7_suppl.542 · Cited by 35
Self-citationD’Haens, G., Vermeire, S., Vogelsang, H., Allez, M., Desreumaux, P., Gossum, A. V., Sandborn, W. J., Baumgart, D. C., Ransohoff, R. M., Comer, G. M., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx128 · Cited by 34
Hassan‐Zahraee, M., Banerjee, A., Cheng, J. B., Zhang, W., Ahmad, A. M., Page, K. M., von Schack, D., Zhang, B., Martin, S. W., Nayak, S., et al. (2017) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjx121 · Cited by 27
Lecuelle, J., Favier, L., Fraisse, C., Lagrange, A., Kaderbhaï, C., Boidot, R., Chevrier, S., Joubert, P., Routy, B., Truntzer, C., et al. (2022) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-004241 · Cited by 25
Self-citationGao, Y., Deason, K. L., Jain, A., Irizarry-Caro, R. A., Dozmorov, I. M., Coughlin, L. A., Rauch, I., Evers, B. M., Koh, A. Y., Wakeland, E. K., et al. (2019) · The Journal of Experimental Medicine · doi:10.1084/jem.20190476 · Cited by 24
Calenda, G., Keawvichit, R., Arrode-Bruses, G., Pattanapanyasat, K., Frank, I., Byrareddy, S. N., Arthos, J. A., Cicala, C., Grasperge, B. F., Blanchard, J., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701150 · Cited by 23
Holmer, A. K., Battat, R. J., Dulai, P. S., Casteele, N. V., Nguyen, N. H., Jain, A., Miralles, A. P., Neill, J., Le, H., Singh, S., et al. (2020) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756284820971214 · Cited by 18
The intracellular metabolome of starving cells
Durand, S., Grajeda‐Iglesias, C., Aprahamian, F., Nirmalathasan, N., Kepp, O., & Kroemer, G. (2021) · Methods in cell biology · doi:10.1016/bs.mcb.2021.04.001 · Cited by 14
Self-citationSonpavde, G., Sternberg, C. N., Loriot, Y., Marabelle, A., Lee, J., Fléchon, A., Roubaud, G., Pouessel, D., Zagonel, V., Calabrò, F., et al. (2022) · European Journal of Cancer · doi:10.1016/j.ejca.2021.12.012 · Cited by 13
Self-citationSidhom, J.-W., Larman, H. B., Pardoll, D. M., & Baras, A. S. (2021) · Nature Communications · doi:10.1038/s41467-021-22667-2 · Cited by 11
Cited by
γδ T cells: origin and fate, subsets, diseases and immunotherapy
Hu, Y., Hu, Q., Li, Y., Lu, L., Xiang, Z., Yin, Z., Kabelitz, D., & Wu, Y. (2023) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-023-01653-8 · Cited by 382
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Self-citationRole of the microbiota in response to and recovery from cancer therapy
Blake, S. J., Wolf, Y., Boursi, B., & Lynn, D. J. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00951-0 · Cited by 158
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic target
Zhang, M., Liu, J., & Xia, Q. (2023) · Experimental Hematology and Oncology · doi:10.1186/s40164-023-00442-x · Cited by 167
Immunosurveillance in clinical cancer management
Kroemer, G., Chan, T. A.-T., Eggermont, A. M. M., & Galluzzi, L. (2023) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21818 · Cited by 177
Self-citation
Metadata
- Authors
- Fidelle, M., Rauber, C., Alves Costa Silva, C., Tian, A.-L., Lahmar, I., de La Varende, A.-L. M., Zhao, L., Thelemaque, C., Lebhar, I., Messaoudene, M., Pizzato, E., Birebent, R., Mbogning Fonkou, M. D., Zoppi, S., Reni, A., Dalban, C., Leduc, M., Ferrere, G., Durand, S., Ly, P., Silvin, A., Mulder, K., Dutertre, C.-A., Ginhoux, F., Yonekura, S., Roberti, M. P., Tidjani-Alou, M., Terrisse, S., Chen, J., Kepp, O., Schippers, A., Wagner, N., Suárez-Gosálvez, J., Kobold, S., Fahrner, J.-E., Richard, C., Bosq, J., Lordello, L., Vitali, G., Galleron, N., Quinquis, B., Le Chatelier, E., Blanchard, L., Girard, J.-P., Jarry, A., Gervois, N., Godefroy, E., Labarrière, N., Koschny, R., Daillère, R., Besse, B., Truntzer, C., Ghiringhelli, F., Coatnoan, N., Mhanna, V., Klatzmann, D., Drubay, D., Albiges, L., Thomas, A. M., Segata, N., Danlos, F.-X., Marabelle, A., Routy, B., Derosa, L., Kroemer, G., & Zitvogel, L.
- Affiliations
- Inserm (FR)
- Gustave Roussy Cancer Campus, Villejuif Cedex, France.
- Centre Hospitalier de l’Université de Montréal (CA)
- University of Parma (IT)
- University of Verona (IT)
- Centre Léon Bérard (FR)
- Universitätsklinikum Aachen (DE)
- Center of Integrated Protein Science Munich (CIPS-M) and Division of Clinical Pharmacology, Department of Medicine IV, Klinikum der Universität München, LMU Munich, Germany.
- Center for Integrated Protein Science Munich (DE)
- JBO Consultant, Paris, France.
- Université Paris-Saclay (FR)
- MetaGenoPolis, INRAe, Université Paris-Saclay, Jouy en Josas, France.
- Centre National de la Recherche Scientifique (FR)
- University Hospital Heidelberg (DE)
- Institut Gustave Roussy (FR)
- University of Trento (IT)
- Corresponding author
- Fidelle, Marine
- Rauber, Conrad
- Derosa, Lisa
- Kroemer, Guido
- Zitvogel, Laurence
- ORCID
- Fidelle, Marine
- Rauber, Conrad
- Alves Costa Silva, Carolina
- Tian, Ai-Ling
- Zhao, Liwei
- Messaoudene, Meriem
- Birebent, Roxanne
- Mbogning Fonkou, Maxime Descartes
- Zoppi, Silvia
- Reni, Anna
- Dalban, Cécile
- Leduc, Marion
- Ferrere, Gladys
- Durand, Sylvère
- Ly, Pierre
- Silvin, Aymeric
- Mulder, Kevin
- Dutertre, Charles-Antoine
- Ginhoux, Florent
- Yonekura, Satoru
- Roberti, Maria Paula
- Tidjani-Alou, Maryam
- Terrisse, Safae
- Chen, Jianzhou
- Kepp, Oliver
- Schippers, Angela
- Wagner, Norbert
- Suárez-Gosálvez, Javier
- Kobold, Sebastian
- Fahrner, Jean-Eudes
- Richard, Corentin
- Bosq, Jacques
- Lordello, Leonardo
- Galleron, Nathalie
- Quinquis, Benoît
- Le Chatelier, Emmanuelle
- Blanchard, Lucas
- Girard, Jean-Philippe
- Jarry, Anne
- Gervois, Nadine
- Godefroy, Emmanuelle
- Labarrière, Nathalie
- Koschny, Ronald
- Daillère, Romain
- Besse, Benjamin
- Truntzer, Caroline
- Ghiringhelli, François
- Coatnoan, Nicolas
- Mhanna, Vanessa
- Klatzmann, David
- Drubay, Damien
- Albiges, Laurence
- Thomas, Andrew Maltez
- Segata, Nicola
- Danlos, François-Xavier
- Marabelle, Aurélien
- Routy, Bertrand
- Derosa, Lisa
- Kroemer, Guido
- Zitvogel, Laurence
- Venue
- Science
- Published
- 2023-06-09
- Volume
- 380
- Issue
- 6649
- Pages
- eabo2296-eabo2296
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W4379780265
- Cited by
- 243
- References
- 83
- Citations by year
- 2026: 74 · 2025: 86 · 2024: 58 · 2023: 25
- FWCI
- 29.63
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- Locations
- Science (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RWTH Publications (RWTH Aachen) (publishedVersion)
- HAL (submittedVersion)
- HAL (submittedVersion, other-oa)
- Institutional Research Information System (Università degli Studi di Trento) (submittedVersion, cc-by)
- Funders
- Agence Nationale de la Recherche (ANR-16-RHUS-0001, ANR-21-ESRE-0028, ANR-18-IBHU-0002, ANR-19-CE15-0029, ANR-21-RHUS-0017, ANR-18-IDEX-0001)
- Topics
- Health Sciences › Medicine › Oncology › Cancer Immunotherapy and Biomarkers
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- antibiotics, gut microbiota, MAdCAM-1, alpha4beta7 integrin, regulatory T cells, anti-PD-1 therapy, tumor immunosuppression, Enterocloster, fecal microbiota transplantation, IL-17A, prognostic factors, lung cancer, kidney cancer, bladder cancer
- MeSH terms
- Gastrointestinal Microbiome, Fecal Microbiota Transplantation, Immune Checkpoint Inhibitors, Animals, Anti-Bacterial Agents, Bacteria, Cell Movement, Humans, Immune Tolerance, Immunologic Surveillance, Mucoproteins, Neoplasms, Cell Adhesion Molecules, Integrins, Drug Resistance, Neoplasm, Interleukin-17, Gastrointestinal Tract, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.